Infection Surveillance Solutions Market : Emerging Market Trends, Opportunities and Business Insights

The rising healthcare expenditure, an increasing number of surgeries, the growing geriatric population, and the increasing incidence of chronic diseases are the other factors driving the growth of this market. Currently, with the surge in COVID-19 cases, there is an increased focus on personal hygiene, coupled with the need to track and monitor the spread of COVID-19 infection. This is further expected to drive the Infection Surveillance Solutions Market growth during the forecast period. The growth of this market is influenced primarily due to the increasing incidence of hospital-acquired infections (HAIs) and new Medicare policies, including non-payment for hospital-acquired conditions.

According to the new market research report global Infection Surveillance Solutions Market size is projected to reach USD 1,033 million by 2026 from USD 508 million in 2021, at a CAGR of 15.2%.

The overall growth of various sectors has been heavily impacted by COVID-19, specifically in countries with a high incidence rate of COVID-19, such as India, China, Brazil, the US, and several European countries (including Russia, Italy, and Spain). While industries such as oil and petroleum, aeronautics, and mining are experiencing a steep fall in revenues, the healthcare, biotechnology, and pharmaceutical industries are optimizing this situation to serve a maximum number of patients and healthcare professionals.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21857517

Based on product and services, the Infection surveillance software market is segmented into software and services. The infection surveillance software segment accounted for the largest share of the market. The large share of this segment can be attributed to the increasing need for preventing HAIs and the growing number of surgical procedures.

Based on type, the infection surveillance software market is segmented into on-premise and web-based software. The on-premise software segment accounted for the largest share of the market. The large share of this segment is mainly attributed to the need for maintaining access to healthcare IT solutions and reduce the risk of data breaches external attacks.

Becton, Dickinson and Company (US), Cerner Corporation (US), Wolters Kluwer N.V. (Netherlands), Premier International Inc. (US), Baxter Corporation (US) are the leading players in the infection surveillance solution market

The global infection surveillance software market is fragmented and highly competitive. Some of the major players governing the overall infection surveillance solutions market include Becton, Dickinson and Company (US), Premier Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Sunquest (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), IBM Corporation (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab Inc. (US), Harris Healthcare (US), PeraHealth Inc. (US), Medexter Healthcare (Austria), Centrak Inc. (US), BioMerieux SA (France), CKM Healthcare (Canada). However, in the last few years, a number of smaller players have emerged from niche markets and are competing with global players based on price and technological innovation. Due to the intense competition in the market, major market players are increasingly focusing on expanding their geographic presence into high-growth emerging markets and strengthening their competitiveness in the market by acquiring smaller players with desired technological capabilities or geographic presence.

Becton, Dickinson and Company is a leading company in the infection surveillance solutions market and is a leading provider of infection surveillance products and services. The company offers a broad range of infection surveillance solutions and has facilities in the U.S., Brazil, Canada, China, France, Germany, Hungary, India, Ireland, Japan, Mexico, the Netherlands, Pakistan, Singapore, Spain, and the U.K. The company operates in three business segments worldwide—BD Medical, BD Life Sciences and BD Interventional. The company offers infection surveillance solutions under the BD Medical segment. MedMined Surveillance Advisor, BD Protect Infection Prevention, and BD AICE are the major infection surveillance software developed and marketed by the company. The company significantly invests in RD activities to add technologically innovative solutions to its portfolio, which helps it to further strengthen its presence in the infection surveillance solutions market.

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=21857517

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments are closed